Filing Details

Accession Number:
0000899243-19-026771
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-06 16:30:33
Reporting Period:
2019-11-04
Accepted Time:
2019-11-06 16:30:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1720725 Oyster Point Pharma Inc. OYST () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1053891 Sacha Lainovic 126 East 56Th Street, 20Th Floor
New York NY 10022
Yes No Yes No
1745076 Invopps Iv Us, L.p. 126 East 56Th Street, 20Th Floor
New York NY 10022
Yes No Yes No
1792570 Invopps Gp Iv, L.l.c. 126 East 56Th Street, 20Th Floor
New York NY 10022
Yes No Yes No
1792575 Invopps Iv, L.p. 126 East 56Th Street, 20Th Floor
New York NY 10022
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2019-11-04 609,965 $0.00 609,965 No 4 C Indirect See Footnotes
Common Stock, Par Value $0.001 Per Share Acquisiton 2019-11-04 1,230,050 $0.00 1,230,050 No 4 C Indirect See Footnotes
Common Stock, Par Value $0.001 Per Share Acquisiton 2019-11-04 248,625 $16.00 858,590 No 4 P Indirect See Footnotes
Common Stock, Par Value $0.001 Per Share Acquisiton 2019-11-04 501,375 $16.00 1,731,425 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnotes
No 4 C Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.001 Per Share Series B Convertible Preferred Stock Disposition 2019-11-04 609,965 $0.00 609,965 $0.00
Common Stock, Par Value $0.001 Per Share Series B Convertible Preferred Stock Disposition 2019-11-04 1,230,050 $0.00 1,230,050 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock (the "Common Stock"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date.
  2. Reflects securities directly held by InvOpps IV US, L.P. ("Invus IV US").
  3. Reflects securities directly held by InvOpps IV, L.P. ("Invus IV").
  4. InvOpps GP IV, L.L.C. ("InvOpps GP") is the sole general partner of each of Invus IV and Invus IV US. Sacha Lainovic is the managing member of InvOpps GP.
  5. Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.